Skip to content

OPEN-LABEL PALATABILITY STUDY OF A NOVEL ORODISPERSIBLE PARACETAMOL/IBUPROFEN FORMULATION AFTER A SINGLE ORAL ADMINISTRATION IN HEALTHY SUBJECTS

Status
Not yet recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2025-524274-41-00
Acronym
FMLD-HUNGRIA-68_PALA
Enrollment
14
Registered
2026-01-14
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteers

Interventions

None listed

Sponsors

Farmalider S.A.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Countries

Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026